Zimmer Biomet Holdings Inc. and Paragon 28 Inc. on Tuesday announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion.
Staff Report | January 29, 2025